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PluripotencyLeukemia inhibitory factor (LIF) is widely used to establish and maintain naïve pluripotent stem cells, including
mouse embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Although the combination of
chemical inhibitors called 2i can establish mouse iPSCs without LIF from primed pluripotent stem cells, it has
been difﬁcult, if not impossible, to establish mouse iPSCs from differentiated somatic cells without LIF. We
previously showed that the fusion gene of the transactivation domain of MyoD and the full-length Oct4 (M3O)
increases the efﬁciency of making iPSCs when transduced into ﬁbroblasts along with Sox2, Klf4, and c-Myc
(M3O-SKM). Here, we report that M3O-SKM allows for establishment of iPSCs without exogenous LIF from
mouse embryonic ﬁbroblasts. The established iPSCs remained undifferentiated and maintained pluripotency
over 90 dayswithout LIF as long asM3Owas expressed. The iPSCs upregulatedmiR-205-5p, whichwas potential-
ly involved in the LIF-independence by suppressing the two signaling pathways inhibited by 2i. The result
indicates that potentiated Oct4 can substitute for the LIF signaling pathway, providing a novel model to link
Oct4 and LIF, two of the most signiﬁcant players in naïve pluripotency.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Leukemia inhibitory factor (LIF) is a key cytokine for themaintenance
of an undifferentiated state (self-renewal) and for the pluripotency of
naïve pluripotent stem cells, including mouse embryonic stem cells
(ESCs) and induced pluripotent stem cells (iPSCs) (Hirai et al., 2011a;
Martello & Smith, 2014). Binding of LIF to its receptor on the plasma
membrane induces heterodimerization of the LIF receptor with another
membrane protein, gp130. This leads to phosphorylation of the
receptor-bound Jak,which in turnphosphorylates the tyrosine at position
705 (T705) in the Stat3 protein. Phosphorylated Stat3 then dimerizes,
enters the nucleus, and binds to between 900 and 2500 genomic loci to
function as a transcription activator or suppressor (Chen et al., 2008;
Kidder et al., 2008).ESC, embryonic stem cell; FBS,
LIF, leukemia inhibitory factor;
embryonic ﬁbroblast; OSKM,
line; qRT-PCR, quantitative RT-
sity of Minnesota, Minneapolis,
f Cardiac Surgery, University of
. This is an open access article underAlthough mouse ESCs and iPSCs are commonly cultured in the
presence of LIF and fetal bovine serum (FBS), they can self-renew in
the absence of LIF and FBS under the 2i condition. This condition con-
tains two chemical inhibitors of signal transduction: a MEK inhibitor
and a GSK3 inhibitor (Ying et al., 2008), although LIF is still frequently
added to reinforce self-renewal (Yang et al., 2010). Overexpression of
one of several genes can also maintain self-renewal of ESCs and iPSCs
in the presence of FBS without LIF. They include Nanog (Chambers
et al., 2003), its downstream factor Esrrb (Festuccia et al., 2012; Zhang
et al., 2008), the upstream factor Tbx3 (Niwa et al., 2009), and Nfya,
which is involved in the binding of Nanog to DNA (Dolﬁni et al.,
2012). Overexpression of genes downstream of Stat3, including Gbx2
(Tai & Ying, 2013), c-Myc (Kidder et al., 2008; Cartwright et al., 2005),
Tfcp2l1 (Martello et al., 2013; Ye et al., 2013), and Klf4 (Niwa et al.,
2009) and its related gene Klf2 (Hall et al., 2009), can also maintain
self-renewal without LIF. Although not directly linked to the LIF-Stat3
pathway, depletion of E-cadherin also allows for self-renewal of ESCs
(Soncin et al., 2009).
In contrast to the maintenance of already-established pluripotency,
acquisition of pluripotency is more stringently dependent on LIF. It
has been difﬁcult, if not impossible, to obtain iPSCs frommouse embry-
onic ﬁbroblasts (MEFs) with the standard gene combination of Oct4,
Sox2, Klf4, and c-Myc (OSKM) and FBS in the absence of exogenous
LIF (Tang et al., 2012). Although Li et al. claimed to have establishedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Li et al., 2009). This indicates that if MEFs or partially reprogrammed
iPSCs secrete any endogenous LIF, it is not sufﬁcient to complete iPSC
formation. Additionally, inhibition of the LIF-Jak pathway with 1 μM
Jak inhibitor I blocks iPSC formation when exogenous LIF was present
(Tang et al., 2012). In a related study, overexpression of Nanog or Klf4
converted primed pluripotent stem cells (epiblast-derived stem cells)
into naïve pluripotent stem cells (iPSCs) in the 2i condition without
LIF; however, the addition of LIF raised the efﬁciency several-fold,
suggesting that these genes cannot fully substitute for the role of LIF
(Yang et al., 2010).
We previously showed that the fusion gene calledM3O, inwhich the
transactivation domain of MyoD is fused to full-length Oct4, raises the
efﬁciency and quality of mouse and human iPSCs (Hirai et al., 2011b;
Hirai et al., 2012). Extending this study, we addressed whether mouse
iPSCs could be established and maintained in the absence of LIF when
M3Owas used instead of Oct4. Hammachi et al. demonstrated that a fu-
sion gene between Oct4 and the transactivation domain of VP16 allows
for self-renewal of ESCs when combined with SKM in the absence of LIF
(Hammachi et al., 2012), although the ESCs grow more slowly than in
the presence of LIF. However, they did not report whether iPSCs could
be established using the fusion gene without LIF. This is an important
question because acquisition of pluripotency is likely to be more
challenging than maintenance of already-established pluripotency. In
the current study, we ﬁrst established a long-term culture of iPSCs
usingM3O along with Sox2, Klf4, and c-Myc (M3O-SKM) in the absence
of LIF and subsequently investigated themolecularmechanismunderly-
ing the establishment.
2. Materials and methods
2.1. Preparation of MEFs
All animal experiments were approved by the Institutional Animal
Care and Use Committee at the University of Minnesota (1302-
30375A). MEFs were prepared from embryonic day (E)13.5 embryos
of Oct4-GFP transgenic mice (B6;129S4-Pou5f1tm2Jae/J; Jackson Labora-
tory, stock #008214) (Lengner et al., 2007). The whole embryos except
for the head and internal organs were minced into small pieces and in-
cubated with collagenase and dispase. After centrifugation at 300 ×g,
the dissociated cells were cultured in ﬁbroblast medium (Dulbecco's
Modiﬁed Eagle Medium [DMEM] with 10% FBS) and frozen for storage
when they became 70–80% conﬂuent.
2.2. Preparation of iPSCs from MEFs
All recombinant DNA research was conducted following the NIH
guidelines. We established four types of iPSCs in this study: O-retro-
iPSCs-LIF(+), O-lenti-iPSCs-LIF(+), M3O-lenti-iPSCs-LIF(+), and M3O-
lenti-iPSCs-LIF(−). O-retro-iPSCs-LIF(+), the most commonly used
type in published studies, was established by transduction of the
OSKM genes into MEFs with the pMXs-IP retroviral vector (Kitamura
et al., 2003) and maintained with LIF. Because integrated lentiviral
transgenes remain active in iPSCs unlike retroviral transgenes, O-lenti-
iPSCs-LIF(+) was prepared with lentiviral Oct4 and retroviral Sox2,Fig. 1. Establishment ofmouse iPSCswithout LIF. (A) Fluorescencemicrographs ofM3O-lenti-iPS
5. GFPwas detectedwith an antibody because ﬁxationwith formaldehyde quenched theGFP. Ba
lenti-iPSCs-LIF(−) on day 5. Bar, 50 μm. (C) Alkaline phosphatase staining ofM3O-lenti-iPSCs-LIF(
various types of iPSCs inwells of a 48-well plate onday 12. TransducedMEFswere seeded at 500 ce
**P b 0.01 with Student's t-test. (E) Concentrations of LIF in the supernatant of feeder cells m
(F) Immunoblotting of phosphorylated T705 in Stat3 (T705-P) and total Stat3 in O-retro-iPSCs-LI
iPSCs-LIF(+) indicates an omission of LIF for 24 h; LIF (+) with M3O-lenti-iPSCs-LIF(−) indicate
LIF(+) andM3O-lenti-iPSCs-LIF(−) after an addition of 1 μM Jak inhibitor I for 24 h. LIFwas added
ber ofGFP-positiveM3O-lenti-iPSCs-LIF(−) colonies, comparing the effect of 1 μMJak inhibitor I an
cells onday 1. iPSC formationwas less efﬁcient in (H) than in (D) becauseMEFswith a higher passa
test in the numbers of GFP (+) colonies between the treatment with 1 μM Jak inhibitor I and DMKlf4, and c-Myc (SKM) tomaintain the expression of the Oct4 transgene
in iPSCs as a control for the twoM3O-based iPSC types.M3O-lenti-iPSCs-
LIF(+)was the same as O-lenti-iPSCs-LIF(+) except thatM3Owas used
instead of Oct4. M3O is a fusion gene in which the ﬁrst 62 amino acids
corresponding to the transactivation domain of the mouse MyoD gene
are fused to the amino terminus of the full-length mouse Oct4 cDNA
(Hirai et al., 2011b). Lentiviral Oct4 and M3O have the FLAG sequence
DYKDDDDK at their carboxyl-termini and were cloned into the
FUW-tetO inducible lentivirus vector to regulate their expression with
doxycycline (Hockemeyer et al., 2008) (Addgene, modiﬁed #20726).
M3O-lenti-iPSCs-LIF(−), the main cell type in the current study, was
the same asM3O-lenti-iPSCs-LIF(+) except that LIF was omitted during
establishment and maintenance.
To prepare the lentivirus suspension, 293T cells were seeded at
3 × 105 to 5 × 105 cells/3.5 cm dish on day-4. Two micrograms of the
FUW-tetO vector encoding M3O or Oct4 was separately transfected
into 293T cells with 1.5 μg of psPAX2 and 0.5 μg of pCMV-VSV-G by
using 10 μl Lipofectamine 2000 (Life Technologies) on day-3. FUW-
M2rtTA (Addgene, #20,342) (Hockemeyer et al., 2008), which encodes
the reverse tetracycline transactivator, was transfected in the sameway.
Themediumwas replacedwith 1.5ml of the ﬁbroblastmedium on day-
2. To prepare the retrovirus suspension, Plat-E cells (Morita et al., 2000)
were seeded at 3×105 to 5× 105 cells/3.5 cmdish on day-4. Fourmicro-
grams of the pMXs-IP vector encoding polycistronic SKM was
transfected into Plat-E cells with 10 μl Lipofectamine 2000 on day-3.
For both lenti- and retrovirus infections, MEFs prepared from Oct4-
GFP transgenic mice were seeded at 5 × 104 cells/well of a 12-well
plate on day-2 in the ﬁbroblast medium. The supernatant containing
each virus was harvested on days-1 and 0 and ﬁltered through a
0.45 μm syringe ﬁlter. The viral supernatant (250 μl) was added to
each well of MEFs along with 10 μg/ml polybrene on days-1 and 0.
Lentiviral M3O and Oct4 were induced with 2 μg/ml doxycycline on
day 1 onwards. The efﬁciency ofmaking iPSCswas calculated as follows.
Transduced MEFs were subcultured on irradiated MEF feeder cells at
2000 cells/well of a 12-well plate in iPSC medium (DMEM, 20% FBS,
100 μM MEM non-essential amino acids, 100 μM 2-mercaptoethanol,
and 2 mM L-glutamine with or without 1000 U/ml LIF) on day 1. The
number of GFP-positive colonies was divided by 2000 to obtain the efﬁ-
ciency of making iPSCs. In some experiments, Jak inhibitor I (Cayman)
was used at 1 μM.2.3. Up- and downregulation of miR-205-5p
miR-205-5p was overexpressed by transfecting 1 or 10 nM of
the miScript miRNA mimic Syn-mmu-miR-205-5p (QIAGEN) with
HiPerFect Transfection Reagent (QIAGEN) on days 1 and 2. We used
two systems to knock down miR-205-5p during iPSC formation: trans-
fection of amiRIDIAN hairpin inhibitor (Thermo Scientiﬁc) or amiScript
inhibitor (QIAGEN) at 0.1, 1, and 10 nM on days 1 and 2, and transduc-
tion of lentiviral shRNA against miR-205-5p (GeneCopoeia) on days-1
and 0. We also knocked out the miR-205-5p gene with the CRISPR/
Cas9 system using two guide sequences overlapping with miR-205-
5p: (#1) 5′-CCGGAGTCTGTCTTATGCCA-3′ and (#2) 5′-TCATTCCACC
GGAGTCTGTC-3′. The CRISPR/Cas9 sequences were separately inserted
into the lentiCRISPR v2 vector (Addgene, #52961) (Sanjana et al.,Cs-LIF(+) andM3O-lenti-iPSCs-LIF(−) colonies double-positive for GFP andNanog onday
r, 50 μm. (B) Immunoﬂuorescence staining of SSEA-1 inM3O-lenti-iPSCs-LIF(+) andM3O-
+) andM3O-lenti-iPSCs-LIF(−) on day 5. Bar, 50 μm. (D) Number of GFP-positive colonies of
lls/well on feeder cells. Results represent themean+SEMof three independent experiments.
easured with ELISA in the presence (+, 1000 U/ml) and absence (−) of exogenous LIF.
F(+) and M3O-lenti-iPSCs-LIF(−) in the presence or absence of LIF. LIF (−) with O-retro-
s an addition of LIF for 24 h. (G) Immunoblotting of T705-P and total Stat3 in O-retro-iPSCs-
to O-retro-iPSCs-LIF(+) but not toM3O-lenti-iPSCs-LIF(−). (H) Temporal proﬁle of the num-
d its solventDMSO. Two thousandMEFswere seeded in eachwell of a 12-well plate on feeder
ge numberwere used in (H). Therewas no statistically signiﬁcant differencewith Student's t-
SO.
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Lentiviruses were prepared as described above and transduced into
MEFs on days-1 and 0 to investigate the effect of the knockout on iPSC
formation.
2.4. LIF ELISA
The concentration of LIF in the supernatant of feeder cells was deter-
mined with a Mouse LIF Quantikine ELISA Kit (R&D Systems, MLF00).
2.5. Immunoﬂuorescence and alkaline phosphatase staining
iPSCs were ﬁxed with 4% formaldehyde in PBS for 10 min. A
Millipore kit (SCR004) was used to detect the expression of alkaline
phosphatase following the manufacturer's instructions. For immuno-
staining, the plasma membrane was permeabilized with 0.5% Triton
X-100 in PBS for 5min. Cells were then stained with primary antibodies
(Table S1) for 1 h, followed by staining with secondary antibodies
(Table S1) for 1 h, both at 25 °C. Hoechst 33342 was used for
counterstaining of DNA. Fluorescence images were acquired with an
AxioCam camera with a 40× LD Acrostigmat Ph2 objective lens on an
Axiovert 200 M microscope (all from Zeiss), or a DP80 camera with a
40× LUCPlanFLN PH2 Phase Plan Achromat objective lens on an IX-81
microscope (all from Olympus). All images were processed with
Adobe Photoshop CS6 and Adobe Illustrator CS6 (Adobe Systems).
2.6. Immunoblotting
iPSCswere treatedwith 1 μM Jak inhibitor I for 24 h, and the levels of
total Stat3 and Stat3 phosphorylated at T705 were analyzed by immuno-
blotting with the antibodies listed in Table S1. The chemiluminescence
signal was detected with a SuperSignal West Dura kit (Thermo
Scientiﬁc).
2.7. Quantitative RT-PCR (qRT-PCR)
Total RNA was prepared from each cell type with a mirVana miRNA
Isolation Kit (Life Technologies). cDNA of mRNA and miRNA was
synthesized using a miScript II RT Kit (QIAGEN). cDNA of mRNA was
subjected to qPCR with a GoTaq qPCR Master Mix (Promega) using
the primers listed in Table S2. qPCR of cDNA derived from miRNA was
performed with a miScript SYBR Green PCR Kit (QIAGEN) with the
primers in miScript Primer Assays (QIAGEN). GAPDH and SNORD61
were used for normalization of the levels of mRNA and miRNA,
respectively.
2.8. Aggregation chimera and teratoma formation
For aggregation of iPSCs with mouse embryos, 8–10 GFP-positive
iPSCs were transferred into a microdrop of KSOM Medium (Millipore)
that contained a zona-free 8-cell-stage mouse embryo of the ICR strain
(albino, Charles River) prepared with brief exposure to acidic Tyrode's
solution (Millipore). To obtain chimeric mice, 2.5-day-postcoital (dpc)
aggregated blastocysts containing GFP-positive iPSCs were transferred
into the uteri of 2.5 dpc pseudopregnant ICRmice. Teratomas were pre-
pared by subcutaneous injection of 1 × 106 iPSCs into 1- to 2-month-old
NOD/SCID mice (Charles River). Four weeks after injection, teratomas
were isolated, ﬁxed with 10% formalin, and embedded in parafﬁn.Fig. 2.Characterization ofM3O-lenti-iPSCs-LIF(−). (A)Double-immunostainingofM3O-lenti-iP
terstainedwithHoechst. Bar, 50 μm. (B) Alkaline phosphatase staining ofM3O-lenti-iPSCs-LIF(−
Sox2 in three types of iPSCs on day 78. The expression level of each gene in CGR8 ESCswas deﬁn
of three independent experiments. (D) Proliferation of M3O-lenti-iPSCs-LIF(−) compared with
feeder cells for 80–100 days before the additional 10 passages shown in this graph. (E) Hema
60 days after intramuscular injection into immunocompromisedmice. M3O-lenti-iPSCs-LIF(−)
mission of M3O-lenti-iPSCs-LIF(−). A chimeric male mouse containingM3O-lenti-iPSCs-LIF(−)
tain brown or black pups (right panel). The iPSCs were derived from 129/B6 mice which displaHistological sections of 5-μm thickness were stained with hematoxylin
and eosin solution.
2.9. Microarray analysis of mRNA
RNAwas prepared fromESCs (CGR8 andCJ7),MEFs, and iPSCswith a
PureLink RNAMini Kit (Life Technologies). Initial sample quality control
was performed with a Nanodrop 8000 (Thermo Scientiﬁc). RNA sam-
ples with an optical density (OD) 260/280 ratio and an OD 260/230
ratio of 1.8 or higher were used. Samples with an RNA Integrity Number
of 7.5 or greater measured with a LabChip Caliper GX (Perkin Elmer)
were applied to an Illumina TotalPrep-96 RNA Ampliﬁcation Kit (Life
Technologies) to generate biotinylated and ampliﬁed RNA. With this
kit, 300 ng of total RNAwas ﬁrst processed in a reverse transcription re-
action. The cDNA then underwent second-strand synthesis and cleanup
to serve as a template for in vitro transcription, which generated bio-
tinylated antisense RNA copies of each mRNA. Samples went through
another round of quality control with the Nanodrop 8000 and were
applied to Illumina MouseWG-6 v2.0 Beadchips (#BD-201–0202).
After overnight hybridization, the Beadchips were washed, stained,
and scanned using an Illumina iScan Beadarray Reader. The obtained
data were analyzed with an Illumina Genome Studio.
2.10. Microarray analysis of miRNA
Microarray assays were performed by a service provider (LC Sci-
ences). Two micrograms of total RNA was extended at the 3′ terminus
with a poly(A) tail using poly(A) polymerase. An oligonucleotide tag
was then ligated to the poly(A) tail for later ﬂuorescent dye staining.
Hybridization was performed overnight on a μParaﬂo microﬂuidic chip
using a microcirculation pump (Atactic Technologies) (Gao et al.,
2004; Zhu et al., 2007). On the microﬂuidic chip, each detection probe
consisted of a chemically modiﬁed nucleotide coding segment comple-
mentary to the target microRNA (miRBase, http://mirbase.org) and a
spacer segment of polyethylene glycol to extend the coding segment
away from the substrate. The detection probes were made by in situ
synthesis using photogenerated reagent chemistry. The hybridization
melting temperatures were balanced by chemical modiﬁcations of the
detection probes. Hybridization used 100 μl 6× SSPE buffer (0.90 M
NaCl, 60 mMNa2HPO4, 6 mM EDTA, pH 6.8) containing 25% formamide
at 34 °C. After RNA hybridization, tag-conjugating Cy5 dye was circulat-
ed through the microﬂuidic chip for dye staining. Fluorescence images
were collected by using a laser scanner (GenePix 4000B, Molecular
Device) and digitized using Array-Pro image analysis software (Media
Cybernetics). Data were analyzed by ﬁrst subtracting the background
and thennormalizing the signals using a LOWESSﬁlter (Locally-weighted
Regression) (Bolstad et al., 2003). The accession number for the mRNA
and miRNA microarray data in the NCBI GEO database is GSE65597.
3. Results
3.1. Establishment and maintenance of mouse iPSCs with M3O-SKM in the
absence of LIF
Because M3O-SKM is highly efﬁcient in creating iPSCs, we tested
whether iPSCs could be established using this gene combination with-
out LIF [M3O-lenti-iPSCs-LIF(−)].We compared the number of colonies
that expressed Oct4-driven GFP between cells with LIF [M3O-lenti-SCs-LIF(−)withGFP andNanog, andGFP and SSEA-1 antibodies, onday 78. DNAwas coun-
) on day 78. Bar, 50 μm. (C) qRT-PCR analysis of Nanog, endogenousOct4, and endogenous
ed as 1.0. Three lines of each iPSC typewere evaluated. Results represent themean+ SEM
M3O-lenti-iPSCs-LIF(+) and O-retro-iPSCs-LIF (+). These cell lines had been cultured on
toxylin and eosin stain of teratoma sections formed by an M3O-lenti-iPSCs-LIF(−) clone
weremaintained without LIF for 90 days before injection. Bar, 100 μm. (F) Germline trans-
(left panel) was matedwith an ICR female (white mouse shown in the right panel) to ob-
yed a brown or black coat color.
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after the transduction of M3O-SKM. GFP-positive colonies appeared
5 days after transduction regardless of the addition of LIF (Fig. 1A).
M3O-lenti-iPSCs-LIF(−), like M3O-lenti-iPSCs-LIF(+), co-expressed an-
other pluripotency marker, Nanog (Fig. 1A). Additional pluripotency
markers, SSEA-1 and alkaline phosphatase, were also expressed in
both types of iPSCs (Fig. 1B and C). The number of GFP-positive colonies
of M3O-lenti-iPSCs-LIF(+) andM3O-lenti-iPSCs-LIF(−) reached a max-
imum aroundday 10 to 12, when the latter produced a half asmany col-
onies as the former (Fig. 1D). In contrast, OSKM [O-lenti-iPSCs-LIF(−)]
did not form any GFP-positive colonies, indicating that the induction
of GFP-positive colonies in the absence of LIF is unique to M3O.
We used ELISAs to measure the concentration of LIF in the superna-
tant of MEF feeder cells cultured with 10% FBS without exogenous LIF.
The concentration was lower than the detection limit of 20 pg/ml (Fig.
1E), which was less than 1% of the concentration used to establish
iPSCs (2100 pg/ml or 1000 U/ml) and insufﬁcient for self-renewal of
ESCs (not shown). To understand whether the LIF-Stat3 signalingFig. 3. Comparison of global expression patterns of mRNA in iPSCs, ESCs, and MEFs. (A) Scatte
MEFs. Average values of two cell lines of each pluripotent cell type and two batches of MEFs w
lines, ESC lines, and MEF batches.pathway was active in M3O-lenti-iPSCs-LIF(−), the level of Stat3 phos-
phorylated at T705 was evaluated with immunoblotting. In the positive
control with O-retro-iPSCs-LIF(+), the level of phosphorylated T705 be-
came substantially lower when LIF was omitted for 24 h comparedwith
the presence of LIF (Fig. 1F). An addition of LIF could increase phosphor-
ylated T705 inM3O-lenti-iPSCs-LIF(−); however, its level remained very
low without LIF, indicating that Stat3 was not activated in M3O-lenti-
iPSCs-LIF(−). We next studied using a Jak inhibitor whether the estab-
lishment of M3O-lenti-iPSCs-LIF(−) was indeed independent of the
LIF-Stat3 pathway. We ﬁrst veriﬁed that 1 μM Jak inhibitor I could
decrease phosphorylated T705 when added for 24 h to already-
established O-retro-iPSCs-LIF(+) (Fig. 1G). An addition of the inhibitor
showed no effect on the already low level of phosphorylated T705 in
M3O-lenti-iPSCs-LIF(−). We then continuously added the inhibitor
from day 1 onward during formation of M3O-lenti-iPSCs-LIF(−). This
procedure did not reduce the formation of M3O-lenti-iPSCs-LIF(−)
compared with the addition of DMSO, the solvent used for Jak inhibitor
I (Fig. 1H). Collectively, these results demonstrated that M3O-lenti-r plots comparing transcriptomes obtained from iPSC lines, ESC lines (CGR8 and CJ7), and
ere used to make the graphs. (B) Pearson correlation of transcriptomes comparing iPSC
Fig. 4. Expression levels of selected miRNAs in MEFs, ESCs, and iPSCs. (A) Microarray analysis of miRNAs whose expression levels in M3O-lenti-iPSCs-LIF(−) were higher than 200% or
lower than 50% of the levels in M3O-lenti-iPSCs-LIF(+). Two cell lines were used for each iPSC type, as represented by the paired columns. (B) qRT-PCR analysis of the miRNAs shown
in (A). The average of two cell lines for each iPSC type is shown. The expression level of SNORD61 was deﬁned as 1.0. None of themiRNAs showed a statistically signiﬁcant difference be-
tween M3O-lenti-iPSCs-LIF(−) and M3O-lenti-iPSCs-LIF(+) (Student's t-test).
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pathway.
M3O-lenti-iPSCs-LIF(−) could maintain self-renewal for at least
90 days in the absence of LIF as long as doxycycline was included in
the culturemedium. They differentiatedwhen doxycyclinewas omitted
and the M3O expression was shut off without LIF; however, they could
continue self-renewal without doxycycline when LIF was added, just
like standard iPSCs established with OSKM [O-retro-iPSCs-LIF(+)].
M3O-lenti-iPSCs-LIF(−) that had been passaged 25 times over 90 days
after viral transduction still maintained a round colony shape and
expressed GFP, Nanog, SSEA-1, and alkaline phosphatase (Fig. 2A and
B). Expression of Nanog, endogenous Oct4 and endogenous Sox2 was
also maintained for 90 days, as determined with qRT-PCR. When three
cell lines of different iPSC types were compared, overall expression
levels of the three pluripotency genes were similar between the cell
lines, although there was some variability (Fig. 2C). The presence or ab-
sence of LIF did not alter the cell proliferation rate during 10 passages of
cells that had already been cultured for 80–100 days in each condition
(Fig. 2D). Upon withdrawal of doxycycline and injection into immuno-
compromisedmice,M3O-lenti-iPSCs-LIF(−) formed teratomas contain-
ing tissues derived from the three germ layers (Fig. 2E). In addition,
germline transmission ofM3O-lenti-iPSCs-LIF(−) occurred after chime-
ra formation (Fig. 2F). These ﬁndings indicate that M3O allows for the
establishment and long-term maintenance of iPSCs without LIF.
3.2. mRNA microarray analysis of M3O-lenti-iPSCs-LIF(−)
We compared genome-wide transcriptome patterns of two ESC
lines, two batches of MEFs, and eight iPSC lines established under vari-
ous conditions. Scatter plots demonstrated that ESCs and iPSCs shared
quite a similar overall pattern, which was highly distinct from that of
MEFs (Fig. 3A). This was also evidentwith a hierarchical cluster analysis
(Fig. 3B). Additionally, we examined whether genes that can maintain
self-renewal of ESCs when overexpressed in the absence of LIF were
more highly expressed in M3O-lenti-iPSCs-LIF(−) than in other iPSCs
or ESCs. Our microarray analysis did not show substantial upregulation
of Nanog, Essrb, Tbx3, Nfya, Gbx2, c-Myc, Tfcp2l1, Klf2, or Klf4
(Figure S1). Cdh1, which encodes E-cadherin, was not downregulated
in M3O-lenti-iPSCs-LIF(−). Thus, LIF-independent establishment of
M3O-lenti-iPSCs-LIF(−) cannot be explained by the altered expression
of these known genes.
3.3. Roles of miR-205-5p in M3O-lenti-iPSCs-LIF(−)
We next examined whether miRNAs may mediate the LIF-
independence of M3O-lenti-iPSCs-LIF(−). We compared the genome-
wide expression patterns of miRNAs in MEFs, ESCs, and various iPSCs
to identify miRNAs that were potentially involved in the LIF-
independence. This study found 11 miRNAs that were expressed in
M3O-lenti-iPSCs-LIF(−) at higher than 200% or lower than 50% relative
to M3O-lenti-iPSCs-LIF(+) (Fig. 4A). However, qRT-PCR conﬁrmed only
miR-205-5p (also written as miR-205) among the 11 miRNAs as fulﬁll-
ing the criteria (Figs. 4B and 5A). In a qRT-PCR analysis,miR-205-5pwas
more highly expressed in ESCs and iPSCs prepared under various condi-
tions than inMEFs (Fig. 5A), which is consistentwith previous reports in
iPSCs (Samavarchi-Tehrani et al., 2010; Li et al., 2010). However, the
connection between miR-205-5p and LIF or iPSCs remains ill deﬁned.
To examine the role of miR-205-5p in iPSC formation, we
overexpressed it in MEFs along with M3O-SKM and OSKM, with orFig. 5.Upregulation of miR-205-5p inM3O-lenti-iPSCs-LIF(−). (A) qRT-PCR analysis of the expr
deﬁned as 1.0. The average value of two cell lines or batches for each cell type is shown. (B) The
miR-205-5p. *P b 0.05 and **P b 0.01 with Student's t-test between 1 nM and DMSO at each tim
the number of GFP-positiveM3O-lenti-iPSCs-LIF(−) colonies. ThemiRNAswere transfected on d
efﬁcient in (C) than in (B) because MEFs with a higher passage number were used in (C). *P b 0
200b-3p, miR-200c-3p, and 10 nMmiR-205-5p did not show a statistically signiﬁcant differenwithout LIF. Overexpression of the miRNA at 1 nM increased the num-
ber of GFP-positive colonies only when M3O-SKM was used without
LIF (Fig. 5B, upper left). This promotion was not observed at 10 nM
miRNA. A similar dose-dependent effect of miRNA has been reported
before. miR-17-92 and let-7a-7f can decrease their target mRNAs only
within a narrow range of concentration speciﬁc to each miRNA; they
lose their effect at higher concentrations (Shu et al., 2012). Although a
mathematical model has been proposed to explain this phenomenon,
the exact mechanism remains elusive. The presence of LIF masked the
positive effect of overexpressed miR-205-5p (Fig. 5B, lower left), and
overexpressedmiR-205-5p showed no effect regardless of the presence
of LIF when OSKM was used (Fig. 5B, two right panels), suggesting the
presence of a synergistic effect between M3O and miR-205-5p.
Along with miR-200b and miR-200c, miR-205-5p is involved in
mesenchymal-to-epithelial transition (MET), an early event during
iPSC formation (Samavarchi-Tehrani et al., 2010; Li et al., 2010; Gregory
et al., 2008). To studywhetherMETwas promoted during the formation
of M3O-lenti-iPSCs-LIF(−), expression levels of miR-205-5p and the
genes involved inmesenchymal-to-epithelial transitionwere evaluated
with qRT-PCR on day 4 in SSEA-1-positive cells, which were enriched
with precursors of iPSCs (Polo et al., 2012). The level of miR-205-5p
was 3.6 times higher in SSEA-1-positive cells isolated from the M3O-
lenti-iPSCs-LIF(−) dishes than those from the M3O-lenti-iPSCs-LIF(+)
dishes (Figure S2). However, the genes associated with epithelium
(Cdh1, Ocln, Cldn3, and Crb3) and mesenchyme (Snai1, Snai2, Zeb1,
and Zeb2) (Samavarchi-Tehrani et al., 2010) were expressed at similar
levels in these cells (Figure S2). We also found that only miR-205-5p
among the three miRNAs involved in MET increased the number of
GFP-positive M3O-SKM colonies upon overexpression in the absence
of LIF (Fig. 5C). These results suggested that MET is not a key effect
underlying the promotion of M3O-lenti-iPSCs-LIF(−) formation by
miR-205-5p.
3.4. Knockout of miR-205-5p with the CRISPR/Cas9 system
As a complementary study, we attempted to deplete miR-205-5p in
MEFs by separately transfecting two inhibitors, but neither of them
decreased the miRNA by more than 20% after repeated transfection at
different concentrations. Transduction of a lentiviral shRNA also failed
to deplete the miRNA by more than 10%. We then turned to knocking
out the miRNA with the CRISPR/Cas9 system, targeting two sequences
in the miR-205-5p genomic locus (Fig. 6A and B). Lentivirus-mediated
transduction of lentiCRISPR v2 can effectively knock out target genes
in a bulk experiment without cloning the cells (Sanjana et al., 2014;
Shalem et al., 2014). Indeed, both CRISPR/Cas9 viruses #1 and #2 down-
regulated miR-205-5p to less than 15% of the control level (Fig. 6C).
However, co-transduction of these viruses with M3O-SKM into MEFs
did not affect the number of GFP-positive colonies compared with the
control, regardless of the presence of LIF (Fig. 6D). This result indicates
that either miR-205-5p is not necessary for the establishment of
M3O-lenti-iPSCs-LIF(−) or other genes can compensate for the lack of
miR-205-5p.
3.5. Downregulation of the Src family kinases and Gsk3β by miR-205-5p
miR-205-5p is known to downregulate the two signaling pathways
that are inhibited by 2i—the ERK1/2 pathway and theGSK3pathway—in
other cell types. miR-205-5p binds to the 3′-UTRs of mRNAs encoding
three members of the Src family of kinases (Src, Lyn, and Yes) andession level of miR-205-5p inMEFs, ESCs, and iPSCs. The expression level of SNORD61was
number of GFP-positive colonies in the presence (1 nMor 10 nM) and absence (DMSO) of
e point. (C) The effects of overexpressed miR-205-5p, miR-200b-3p, and miR-200c-3p on
ays 1 and 2.MEFswere seeded at 500 cells/well of a 48-well plate. iPSC formationwas less
.05 and **P b 0.01 with Student's t-test between 1 nM and DMSO at each time point. miR-
ce between the transfection of each miRNA and control RNA.
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Fig. 6. Knockout of miR-205-5p with CRISPR/Cas9. (A) Sequences of miR-205-5p (red) and miR-205-3p (green). (B) Guide sequences of lentiCRISPR v2 #1 and #2 targeting miR-205-5p.
The red and green sequences correspond to the miR-205-5p andmiR-205-3p sequences, respectively shown in panel (A). (C) qRT-PCR result demonstrating the expression level of miR-
205-5p upon knockout of themiRNAwith CRISPR/Cas9 on day 5 during formation ofM3O-lenti-iPSCs-LIF(−). (D) Number of GFP-positive colonies in a well of a 48-well plate usingM3O-
SKM with and without LIF. A lentivirus encoding CRIPSR/Cas9 targeting the miR-205-5p locus was co-transduced. The control virus did not include a guide RNA sequence.
478 H. Hirai et al. / Stem Cell Research 15 (2015) 469–480downregulates their protein levels, resulting in the inhibition of the
ERK1/2 pathway as a downstream effect in renal carcinoma cells
(Majid et al., 2011). Overexpressed miR-205-5p in preadipocytes
decreases the GSK3β protein through its binding to the 3′-UTR of its
mRNA (Yu et al., 2014). Indeed, our qRT-PCR result demonstrated that
mRNA levels of Src, Lyn, Yes1, and GSK3β were lower in M3O-lenti-
iPSCs-LIF(−) than in M3O-lenti-iPSCs-LIF(+) and O-retro-iPSCs-LIF(+) (Fig. 7A). In addition, overexpressed miR-205-5p further de-
creased the expression levels of the four target genes (Fig. 7B). Howev-
er, knockout of miR-205-5p did not upregulate the four genes, contrary
to our expectation (Fig. 7C). We also examined whether overexpressed
miR-205-5p could maintain iPSCs undifferentiated in the absence of 2i
and LIF but the cells differentiated under this condition. This indicates
that miR-205-5p cannot fully substitute for 2i.
Fig. 7. Alteration of the expression levels of the Src family genes and Gsk3β by miR-205-5p. (A) qRT-PCR analysis of the Src family genes and Gsk3β in iPSCs established under various
conditions. Relative expression ratio to GAPDH mRNA is shown. *Student's t-test P b 0.05 and **P b 0.01. (B) Downregulation of the Src family genes and Gsk3β upon overexpression
of 1 nMmiR-205-5p during formation of M3O-lenti-iPSCs-LIF(−). Relative expression ratio to GAPDH mRNA is shown for all but miR-205-5p. For miR-205-p, the expression level after
transduction of a control miRNA (QIAGEN) was deﬁned as 1.0. **P b 0.01 and *** P b 0.001. (C) Relative expression of the Src family genes and Gsk3β after knockout of miR-205-5p during
formation ofM3O-lenti-iPSCs-LIF(−). Lentivirus encoding CRIPSR/Cas9 targeting themiR-205-5p locus (#1)was transduced. The cells were applied for qRT-PCR 6 days later. *P b 0.05 and
**P b 0.01.
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The current work showed that M3O-SKM allows for the establish-
ment and maintenance of iPSCs in the absence of exogenous LIF. We
also showed that miR-205-5p synergizes with M3O-SKM. More than
20 individuals or families of miRNAs play critical roles in self-renewal
and pluripotency in ESCs and iPSCs by regulating numerous target
genes (Moradi et al., 2014; Greve et al., 2013); however, their connec-
tionswith LIF/Stat3 remains ill deﬁned, andmiR-205-5p is no exception.
LikemousemiR-205-5p, humanmiR-205-5p, whose sequence is identi-
cal to its mouse counterpart, is more highly expressed in human ESCs
and iPSCs than in ﬁbroblasts (Wilson et al., 2009). In addition, Oct4,
Sox2, and Nanog proteins bind to the genomic locus of miR-205 in
ESCs, suggesting direct regulation by the pluripotency master proteins
(Marson et al., 2008). However, miR-205-5p is not essential for
pluripotency of early embryos, because mice lacking this miRNA can
survive until around 10 days after birth, when they die with severe
skin defects (Wang et al., 2013). Li et al. reported that threefold overex-
pression of miR-205-5p in mouse ESCs leads to differentiation into
extraembryonic endoderm in the presence of LIF (Li et al., 2013).Somewhat consistently, our result indicates that the positive effect of
miR-205-5p in iPSC formation becomes obvious only under a speciﬁc
condition—used at 1 nM with M3O to potentiate Oct4 in the absence
of LIF.
We showed the capability ofmiR-205-5p to downregulate Src family
kinases and Gsk3β in M3O-lenti-iPSCs-LIF(−) but knockout of the
miRNA did not upregulate the target genes. More detailed study of
these effects would require a genome-wide gene expression analysis
in M3O-lenti-iPSCs-LIF(−) after up- and downregulation of miR-205-
5p, which is beyond the scope of the current study. Perhaps a more fun-
damental message about the wider impact of the current study would
be that ampliﬁcation of Oct4 activity with the MyoD domain can elimi-
nate the necessity of LIF. This could be due to higher expression of the
genuine Oct4 target genes and/or expanded target genes. Our microar-
ray analysis of mRNAs excluded the possibility that genes already
known to substitute for LIF were upregulated by M3O-SKM, suggesting
the existence of other genes that can compensate for the lack of LIF.
Future studies on the differentially expressed mRNAs could potentially
reveal a novel connection between Oct4 target genes and the LIF signal-
ing pathway.
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